Intra-operative evaluation of the sentinel lymph node for T1-N0 breast-cancer patients: always or never? A risk/benefit and cost/benefit analysis

G. Canavese (1) , P. Bruzzi (1) , A. Catturich (1) , C. Vecchio (1) , D. Tomei (1) , F. Carli (1) , M. Truini (1) , G.B. Andreoli (1) , V. Priano (1) , B. Dozin (1)

1 National Cancer Research Institute

To investigate whether omitting intra-operative staging of the sentinel lymph node (SLN) in T1-N0 breast-cancer patients is feasible and convenient because it could allow a more efficient management of human and logistic resources without leading to an unacceptable increase in the rate of delayed axillary lymph node dissection (ALND).

Mots clés: breast cancer; sentinel lymph node; intra-operative evaluation; axillary lymph node dissection

G. Canavese, P. Bruzzi, A. Catturich, C. Vecchio, D. Tomei, et al.. Intra-operative evaluation of the sentinel lymph node for T1-N0 breast-cancer patients: always or never? A risk/benefit and cost/benefit analysis. EJSO - European Journal of Surgical Oncology, 2010, 36 (8), pp.737. ⟨10.1016/j.ejso.2010.06.010⟩. ⟨hal-00608926⟩